NAFLD in Diabetes Type 2 in Primary Care (EPSONIP)

Linköping University (LiU)

Status: Completed

Conditions: NAFLD

Study type: Observational

Funder types: Other

Identifiers

NCT03864510

2018:176-31

Details and patient eligibility

About

The EPSONIP (Evaluating Prevalence and Severity Of NAFLD In Primary care) trial is a longitudinal cohort study of patients with T2DM recruited from primary health care centers in Östergötland, Sweden. The latest MRI techniques will be used to quantify the amount of hepatic fat, inflammation, liver fibrosis and body composition. Each patient will be investigated twice with three years apart to determine patients with progressive disease.

Enrollment: 317 patients

Sex: All

Ages: 35 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetes type 2
• Age 35-75 year

Exclusion criteria

• Contraindication to MR
• Alcohol dependance
• Previously diagnosed liver cirrhosis
• Previously known liver disease (other than fatty liver)